SEC Tracker
Get the app

Bolt Biotherapeutics BOLT

Bolt Biotherapeutics extends lease

Form
8-K
Filed
Importance
Routine
  1. Paid $1.0 million to Landlord
  2. Lease expires Dec 31, 2027
  3. Potential $4.5 million termination payment
  4. Ongoing rent not significant

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Bolt Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Intensity Therapeutics INTS public float $7M, Jun 30, 2025
  2. Zeo ScientifiX ZEOX public float $7M, Apr 30, 2025, over 18 months old
  3. Genprex GNPX public float $8M, Jun 30, 2025
  4. VivoSim Labs VIVS public float $8M, Sep 30, 2025
  5. Sunshine Biopharma SBFM public float $7M, Jun 30, 2025